ESPOO, Finland, 30th of March 2021 – Picosun Group reports strong growth and a positive operating profit from its fiscal year 1.1.2020-31.12.2020.
Fiscal year 2020 in short*
• Order intake grew by 48,4% and was €40,9M (€27,5M)
• Turnover grew by 38,6% and was €37,6M (€27,1M)
• Operating profit was €0,9M (€-0,3M), which is 2,5% (-1,1%) of the turnover
A bigger portion of the new order intake and turnover, compared to previous years, consisted of sales of machines meant for production in the industry and medical sector. The growth was especially strong in Asia and Europe. Service business represented 16% (12%) of 2020 order intake.
“Despite the COVID-19 challenges we were able to continue on our growth path as planned. The pandemic led to increased investments in the medical sector. Also, remote work and the increased interest in entertainment applications grew the demand of production machines in electronics and semiconductor industries”, states Jussi Rautee, CEO of Picosun Group.
New investments in medical industry
Picosun has been involved in product development for the medical sector for some time. Protecting for example medical implants with ALD from the corrosive environment of the human body, and vice versa, is of utmost importance considering the safety, correct operation, and lifetime of the implant.
The company established a new business area, PicoMedical, in response to the increased interest and needs of the medical and healthcare ALD segments. PicoMedical’s order intake in 2020 constituted 10% of the company’s new order intake.
”We in Picosun believe that ALD will disrupt the medical industry the same way it did in the semiconductor industry. Our aim is to be the forerunner in this development”, says Jussi Rautee.
Almost a fifth of company’s turnover to research and development
During 2020 Picosun Group continued investing in its R&D functions. The company invested 18% of its turnover to various research and development activities. During 2020 Picosun filed 16 new patent applications at the European Patent Office, and 34 patent applications in various countries were granted to Picosun.
The company brought a number of significant new products to the semiconductor market. PICOSUN® Sprinter, a high throughput ALD production module for 300 mm wafers, was launched late 2020. PICOSUN® Morpher product family, designed for 200 mm wafers, grew with Morpher P (PE-ALD). For easy, intuitive and user-friendly operations of the whole PICOSUN® ALD cluster, the company launched its unified control software PicoOS™.
“Our commitment to meet our customers’ needs proactively and ensuring their future success resulted in the development work and launches that took place in 2020. This is part of ongoing work that we are continuing this year. We are also further developing ways to be in contact with our customers. Last year we took into use the leading remote support tools, taking advantage of e.g. augmented reality, that allow safe and on-time service delivery no matter the physical location of the customer”, says Jussi Rautee.
*Numbers in the brackets are 2019 non-audited consolidated numbers based on management reports.
Picosun provides the most advanced AGILE ALD® (Atomic Layer Deposition) thin film coating solutions for global industries. Picosun’s ALD solutions enable technological leap into the future, with turn-key production processes and unmatched, pioneering expertise in the field – dating back to the invention of the technology itself. Today, PICOSUN® ALD equipment are in daily manufacturing use in numerous leading industries around the world. Picosun is based in Finland, with subsidiaries in Germany, USA, Singapore, Japan, South Korea, China mainland and Taiwan, offices in India and France, and a world-wide sales and support network. Visit www.picosun.com.
Mr. Kustaa Poutiainen
Chairman of the Board
Tel: +358 400 424 506
Mr. Jussi Rautee
CEO, Picosun Group
Tel: +358 50 345 4457